Search Results

web-platform for pharmacogenomics research Trinh Trung Duong Nguyen ,  Ziaurrehman Tanoli ,  Saad Hassan , Umut Onur Özcan ,   Jimmy Caroli ,   Albert J Kooistra ,   David E Gloriam ,   Alexander S Hauser GPCRdb Schedule a session with our Chief Match Maker. Direct line to the Dr. 🕵️‍♂️We'll soon be unveiling our University CheatSheet! Major Announcement! This will support our operations and community growth.

🔔 Subscribe to our monthly newsletter for FREE! ➡️ https://bit.ly/3cCI4em #gpcr #drgpcr

Drug discovery does not move in fixed conclusions. As datasets expand and systems are tested under new conditions, interpretations often require adjustment. What initially appears mechanistically clear can become more nuanced when additional experiments are layered in. Terry’s Pharmacology Corner is built around that reality. It is designed as a continuous learning environment — supporting scientific reasoning as programs mature, rather than treating pharmacology as a one-time lesson. The analysis below emerged from a recent live Ask Me Anything (AMA) session, where members brought forward active questions from their GPCR discovery efforts. The AMA format enables careful examination of evolving data — from Schild slope interpretation to probe dependence and kinetic validation — in real time. Through structured lectures, monthly live AMAs, and full replay access, the Corner provides ongoing refinement of pharmacological judgment across the lifespan of a program. The next live AMA will take place: Thursday, February 26th at 12:00 PM EST You are invited to submit questions in advance to: terry@drgpcr.org Distinguishing Orthosteric vs Allosteric Mechanisms in GPCR Drug Discovery Programs Pharmacologists know the pressure of distinguishing between orthosteric and allosteric drug mechanisms—especially when structural data is unavailable. Functional assays can suggest clarity while quietly masking complexity, creating the illusion of competitive antagonism or obscuring subtle allosteric behavior. Misinterpretation does more than delay progress. It can redirect chemistry strategy, distort translational assumptions, and conceal liabilities that emerge only in vivo or in the clinic. What if a seemingly “clean” antagonist profile reflects silent allosteric modulation? What if probe dependence is quietly signaling selective safety implications? Each experimental decision — system sensitivity, assay configuration, kinetic design — carries strategic consequences. In this session, we explored: Strategic frameworks for early discrimination of orthosteric vs allosteric effects Conceptual tools for interpreting Schild plot deviations and probe dependence Operational practices that strengthen GPCR discovery pipelines Operationalizing Allosteric Signatures Early workflows often rely on rapid “one-way” experiments — screens that may reveal allosteric behavior but cannot definitively exclude it. A substantial rightward shift in a dose–response curve is frequently interpreted as competitive antagonism. However, negative allosteric modulators (NAMs) with modest cooperativity can mimic orthosteric competition across wide concentration ranges. The defining distinction is saturation: Saturation defines the allosteric boundary  — additional modulator produces no further shift. Orthosteric antagonists remain theoretically unlimited  — competition continues as concentration increases. Recognizing this difference early prevents mechanistic misclassification. Interpreting Schild Plots — Curves and Slopes Schild analysis remains foundational, but interpretation requires discipline. When a system approaches full allosteric occupancy, the Schild plot curves and the slope falls below unity — signaling that competitive assumptions no longer apply. Key diagnostic considerations: Curved Schild plots suggest occupancy-limited modulation Linear plots with slope ≠ 1 demand investigation  — equilibration time, receptor heterogeneity, or system-level factors must be assessed before mechanistic conclusions are drawn A slope is not merely a fitted parameter. It is a diagnostic signal. Probe Dependence — A Distinctive Allosteric Readout Allosteric systems exhibit probe dependence: the same modulator can shift one agonist thirty-fold and another six-fold. This variability is not noise — it is mechanistic information. Probe dependence reveals hidden selectivity and efficacy shifts It becomes critical in both screening strategy and therapeutic positioning As ligand diversity expands — including peptide agonists and biased ligands — ignoring probe dependence risks overlooking clinically meaningful distinctions. Assay Sensitivity and System Configuration Receptor expression level is a strategic variable. High-expression systems maximize detection sensitivity and can reveal subtle efficacies. Low-expression systems expose whether observed potency reflects intrinsic efficacy or simple binding strength. This “tissue volume control” becomes essential when: Distinguishing affinity-dominant from efficacy-dominant agonists Detecting silent partial agonism Extracting operational model parameters with translational relevance System configuration shapes interpretation. Decoding Kinetics — The Allosteric Differentiator Kinetic experiments provide definitive mechanistic evidence. Only allosteric modulators alter the onset or offset of agonist responses. Demonstrating changes in association or dissociation rates moves analysis beyond functional shifts toward mechanistic proof. Allosterics modify agonist kinetics Orthosteric competitors do not For publication-grade validation and regulatory confidence, kinetic evidence becomes indispensable. Strategic Use of Repurposing and Data Controls Drug repurposing offers reduced uncertainty and extensive prior data. Yet rare adverse effects may only emerge after large-scale exposure, and selectivity must still be demonstrated rigorously. Meanwhile, controls remain non-negotiable. GPCR systems are sensitive and context-dependent. Pathway bias, tissue sensitivity, and system artifacts can distort interpretation if not carefully managed. Robust controls distinguish mechanism from artifact Multipathway analysis reduces false confidence Neglecting these elements invites downstream surprises. Integrating Chemistry and Kinetics Early Biological activity alone does not define a viable series. Chemical tractability, early safety screens (e.g., hERG), ADME properties, and residence time often determine long-term success. Potency can attract attention, but residence time and target engagement kinetics frequently better predict in vivo performance. Strategic discipline means: Screening liabilities early Integrating chemistry insights immediately Avoiding advancement of scaffolds likely to collapse later “Fail early” is not pessimism. It is resource stewardship. Best Habits for Data Quality and Reproducibility Detection assays identify activity; they do not validate therapeutic viability. Repetition without purpose consumes time. Statistical rigor prevents wishful interpretation. Quantitative follow-up studies separate true signal from noise. Advance promising hits into mechanistic evaluation quickly Use statistics to arbitrate interpretation Design assays deliberately Interpretive discipline is the foundation of reproducible pharmacology. Why Terry’s Pharmacology Corner Mechanistic understanding evolves. What appears settled under one experimental condition may require refinement under another. Terry’s Pharmacology Corner provides a structured environment for that evolution: Weekly advanced pharmacology lectures Monthly live AMAs for real-time scientific discussion A continually expanding on-demand archive Sustained exposure to disciplined mechanistic reasoning The value lies not in a single explanation, but in maintaining interpretive rigor as programs mature. Forty years of pharmacological expertise — organized into a year-round learning framework for serious GPCR scientists. Explore the full library ➤

our systems  — and stepping confidently into what’s next. GPCR stronger, more connected, and more capable of supporting our growing community. Our strategic partnerships  reflect that mission. Our Ambassador Program empowers community members to share Dr. From free resources like the podcast and blog to our Premium ecosystem and Foundry initiatives, our mission

. 🌟 Speaker Spotlight In the run-up to the conference, our founder Yamina Berchiche is speaking with GPCR , our mission is simple: connect the GPCR community, share knowledge, and accelerate innovation At Yamina's Corner , our founder Yamina Berchiche works closely with organizations to help them navigate Foster collaboration  through our platform and events. It’s the only  resource of its kind — part masterclass, part fireside chat — available anytime to our

For our very first post in this ecosystem, we wanted to highlight a huge part of our work at Celtarys You can check what we do here on our website!   completely, otherwise it can quelate biomolecules or induce cell toxicity. [ 5]     At Celtarys’ we have our conjugation strategy - our own proprietary technology- which bypasses some of the issues seen before Besides, it’s an eco-friendlier method, which always helps future-proof our probes! 

GPCR updates: sharpen your skills with our new on-demand course, Techniques for Effective Lead Optimization Terry Kenakin, and catch up on cutting-edge insights through our full library of symposia recordings, We’re also spotlighting breakthroughs that challenge dogma and deepen our view of receptor dynamics, Arrestin2 binds β₁AR without ligand-induced activation, reshaping our understanding of biased signaling

Join us now, and let's explore with all our might! Act fast to secure your place in our upcoming course ! Rave Reviews from Our Satisfied Students Past students highly recommend our programs, praising our faculty's Take action immediately to join our esteemed learning community! Get ready to be blown away by our fantastic lineup of speakers HERE !

To fully explore our Ecosystem, scroll to the footer and check out our Map! our exceptional features: Dr. Book a date with our Chief Match Maker! Direct line to the Dr. We're about to reveal our University CheatSheet —a sneaky peek at all our talks, presentations, and courses It'll help us keep things running smoothly and grow our community.

We got a little busy with all the major events at Dr.GPCR, so our weekly news looks slightly different We will be back next week with our regular weekly GPCR news digest. Today is also the first session of our hands-on workshop with Dr. Sam Hoare.

Don’t miss out on our GPCR coverage for this week. GPCR Symposia We extend our heartfelt thanks to all speakers and participants for making our recent Dr on our platform. If you participated in our symposiums, please take a moment to complete this survey. Sam Hoare as our instructor. Under Dr.

Make sure you get our latest coverage of GPCRs for this week. public on our website! Our most recent episode features our very own Dr. GPCR Board. Tune in and enjoy! Dr. GPCR Matchmaking Meet Mark Schmeizl, our Chief Matchmaker. GPCR Symposia Explore GPCRs with our Premium Membership!

Check out our GPCR coverage for this week. GPCR Symposia Our upcoming symposium on March 15th is about GPCR activation and signaling. You can sign up for our waitlist. We will be offering this live course later this year. GPCR Volunteers Join our dynamic team as a volunteer! April 22 - 23, 2024 | Endocrine Metabolic GPCRs Join our Founder Dr.

Yamina’s Corner opens for strategic consulting, and our partner Celtarys unveils a robust TR-FRET assay GPCR Team Join Our Newsletter! To start receiving our newsletter in your inbox every Thursday, follow these simple steps: Select the

This Week’s Highlights: Congrats to: Our contributor, Cam Sinh Lu ,  who has just released an incredible article on our site and a GPCR Paper with his team: Targeted Drug Design through GPCR Mutagenesis: Insights Secure your spot now for our next course . Positive Feedback from Our Esteemed Students Past students highly recommend our programs, lauding the Take action immediately to join our esteemed learning community!

We're excited to share our coverage of the latest developments in GPCRs for this week. Join our upcoming Dr. GPCR University hands-on workshop with Dr.  Do you want to re-watch our recorded events? This is an excellent opportunity to network and increase your visibility on our platform. If you've participated in our symposiums, please take a few minutes to complete this survey.

Hi everyone, Take a moment to explore our latest coverage of GPCRs this week, which includes 7 insightful Experience the full impact of our discussions with our new video format. Witness the passion and excitement of our guests as you catch up on missed episodes. GPCR Event Highlight We’re excited to announce our in-person event in collaboration with the Adhesion

Check out our GPCR coverage for this week. Join our upcoming Dr. GPCR University hands-on workshop with Dr.  Submit a few slides for a poster presentation to showcase your research and network with our community Remember to give us your feedback by completing our survey if you've participated in our symposiums. GPCR Matchmaking Did you check out our first job opportunity spotlight for a Principal Scientist In Vitro

Join our upcoming Dr. GPCR University hands-on workshop with Dr.  GPCR Symposia Join us on June 7th for our symposium on Structural and Molecular Insights into GPCR Function Submit a few slides for a poster presentation to showcase your research and network with our community Don't forget to give us your feedback by completing our survey if you've participated in our symposiums GPCR Matchmaking Did you check out our first job opportunity spotlight for a Principal Scientist In

This Week’s Highlights: Our fearless leader, Yamina Berchiche , is gearing up to rock the mic today at Registration is open for our November class . Our Students Highly Recommend Us! Our goal is to ensure that education is within reach for everyone! Act Now and Become a Valued Member of our Learning Community!

There are only 5 spots left for our upcoming courses, so seize the chance to learn from the best in Gain access to over 500 minutes of recorded classes in our  GPCR courses   taught by Drs. Our Students Highly Recommend Us! Previous students praise the course content and our exceptional service. Our goal is to ensure that education is within reach for everyone!

Check out our GPCR coverage for this week. Join our upcoming Dr. GPCR University hands-on workshop with Dr.  Check our conversation with Dr. Sam Hoare about this hands-on workshop HERE ⬇⬇⬇ Dr. Do you want to re-watch our recorded events? This is an excellent opportunity to network and increase your visibility on our platform.

Our updated course schedule is designed to fit seamlessly into your routine, offering an enriched learning And access over 500 minutes of recorded classes in our  GPCR courses with Drs. Affordable & Unique Learning Experience Our budget-friendly courses offer a unique approach to mastering Our Students Love Us! Past students rave about the content and service of our courses. Our goal is to ensure that education is within reach for everyone!

This lesson asks a deceptively simple question: What if our molecules—not our targets—are limiting discovery The key question Terry raises: If natural scaffolds provided our starting pharmacology, what new scaffolds Allostery and Biased Signaling Change the Game The most profound change in GPCR drug discovery is our

Check out our GPCR coverage for this week. GPCR Symposia Our upcoming symposium on March 15th is about GPCR activation and signaling. Additionally, if you participated in our Symposia in 2023, please take a moment to fill out this survey You can sign up for our waitlist. We are considering rerunning this live course later this year. GPCR Volunteers Join our dynamic team as a volunteer!

Gain access to over 500 minutes of recorded classes in our  GPCR courses   taught by Drs. Our Students Highly Recommend Us! Past students praise the course content and our exceptional service. Our goal is to ensure that education is within reach for everyone! Take Action Now and Join our Community of Learners!

Don't miss out on our latest coverage of GPCRs for this week. GPCR University We successfully started our Dr.GPCR University workshop, 'Advanced Data Analysis for A special episode with our board, meet Drs. Maria Waldhoer, JoAnn Trejo, and Anne Marie Quinn. We have postponed our symposium on Structural Insights into GPCR Activation to a later date. Stay tuned for our next symposium on GPCRs as Therapeutics Targets on October 11th, 2024.

Stay up-to-date with the latest GPCR research, including breakthrough studies, upcoming events, and our Don't miss exclusive discounts, expert insights, and opportunities to elevate your learning with our Plus, access to over 500 minutes of recorded classes of our GPCR Courses with Drs. Don't miss out on our fantastic discussion with Dr. Don’t miss this chance to benefit from our early bird pricing and premium content.

Our mission is simple: bridge science and industry  by connecting researchers, biotech, CROs, and pharma Our Sponsors This event would not be possible without the generous support of our sponsors: NIS Proteos

We are dedicated to enhancing our community and delivering exceptional services to achieve our goal of leading a vibrant and healthy life , all thanks to the incredible potential of our beloved GPCRs. Join our fantastic tribe today by becoming a DrGPCR Premium Member ! Book a session with our Chief Match Maker. Direct line to the Dr. We're working hard to keep the lights on and the coffee brewing by sprinkling a bit of magic on our revenue